When normalized to this decreased vascular volume, the accumulation of albumin-EB 24 hours post IV injection of the dye in cancers is increased (p<0.05) by 60% compared to non-tasquinimod treated hosts, with no change in normalized accumulation in either the kidney or liver, Figure 3C. This evidence concerns the gene ALB and cancer.